首页> 外文OA文献 >New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

【2h】

New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

机译：通过选择性前列腺细胞中靶向雄激素受体使用ASC-J9抑制去势抵抗性前列腺癌的新治疗方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lai Kuo-Pao; Huang Chiung-Kuei; Chang Yu-Jia; Chung Chin-Ying; Yamashita Shinichi; Li Lei; Lee Soo Ok; Yeh Shuyuan; Chang Chawnshang;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells [J] . LaiK.-P., HuangC.-K., ChangY.-J., American Journal of Pathology: Official Publication of the American Association of Pathologists . 2013,第2期

机译：通过靶向雄激素受体的选择性前列腺细胞中的ASC-J9抑制去势抵抗性前列腺癌的新治疗方法
2. New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer using ASC-J9(R) via Targeting Androgen Receptor in Selective Prostate Cells [J] . Kuo-Pao Lai, Chiung-Kuei Huang, Yu-Jia Chang, The American journal of pathology. . 2013,第2期

机译：通过选择性前列腺细胞中靶向雄激素受体使用ASC-J9（R）抑制去势抵抗性前列腺癌的新治疗方法
3. Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells [J] . NakkaM., AgoulnikI.U., WeigelN.L. The international journal of biochemistry and cell biology . 2013,第4期

机译：靶向破坏雄激素受体（AR）的p160共激活因子接口选择性抑制雄激素依赖性和去势抵抗的AR表达前列腺癌细胞中的AR活性
4. Black Tea Polyphenols Theaflavins Inhibit the Growth of LNCaP Prostate Cancer Cells through Suppressing Androgen Receptor and 5α-Reductase Activity [C] . Jen-Kun Lin, Hung-Hsiao Lee, Chi-Tang Ho Dietary supplements . -1

机译：红茶多酚茶黄素通过抑制雄激素受体和5α-还原酶的活性抑制LNCaP前列腺癌细胞的生长
5. Therapeutic Targeting of Stat5a/b in Advanced Prostate Cancer: Inhibition of Stat5a/b Suppresses Growth of Prostate Cancer through Mechanisms Dependent and Independent of Androgen Receptor. [D] . Hoang, David Timothy. 2016

机译：Stat5a / b在晚期前列腺癌中的治疗靶点：Stat5a / b的抑制作用通过依赖于雄激素受体的机制来抑制前列腺癌的生长。
6. New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells [O] . Kuo-Pao Lai, Chiung-Kuei Huang, Yu-Jia Chang, 2013

机译：通过选择性前列腺细胞中靶向雄激素受体使用ASC-J9抑制去势抵抗性前列腺癌的新治疗方法
7. Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells [O] . Manjula Nakka, Irina U. Agoulnik, Nancy L. Weigel 2013

机译：雄激素受体（Ar）的P160共粘膜界面的靶向破坏选择性地抑制雄激素依赖性和抗阉割的抗溶胀AR的前列腺癌细胞中的AR活性
8. Does the Androgen Receptor (AR)-Regulated Map Kinase Phosphatase 1 (MKP-1) Enhance Castration-Resistant Prostate Cancer Survival under Therapeutic Stress? [R] . Szmulewitz, R. 2016

机译：雄激素受体（aR）调控的地图激酶磷酸酶1（mKp-1）是否在治疗应激下增强去势抵抗性前列腺癌的存活？

New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

著录项

引文网络

相似文献

相关主题

期刊订阅